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Executive summary 
 
The European Union Reference Laboratory for Polycyclic Aromatic Hydrocarbons and Process 
Contaminants, hosted by the Joint Research Centre of the European Commission, organised on 
request of the Directorate-General SANTE a method validation study via collaborative trial to 
evaluate the performance of a method for the determination of fatty acid esters of 3-
monochloropropane-1,2-diol (3-MCPD-ester), 2-monochloropropane-1,2-diol (2-MCPD-ester) 
and glycidyl esters (GEs) in food samples. 
 
The method validation study was conducted according to the International Union for Pure and 
Applied Chemistry harmonised protocol and the Collaborative Study Guidelines of AOAC 
International for blind (unpaired) replicates. The method was applied for the determination of 
3-MCPD-, 2-MCPD-esters and GEs in naturally contaminated oil, fat, waffles, potato chips 
(crisps) and crackers. 
 
The standard operating procedure was based on the extraction of the test materials by 
pressurised liquid extraction, followed by acid transesterification and derivatisation of the 
released free (non-esterified) form with phenylboronic acid. The determination was carried out 
by gas chromatography-mass spectrometry with electron ionisation in selected ion monitoring 
mode. 
 
The trial involved 10 participants, representing a cross section of research, private and official 
control laboratories from 4 EU Member States (Germany, UK, Ireland and The Netherlands), 
USA and Japan. The selection of collaborators was based on the performance in a pre-trial, 
organised prior to the collaborative trial with the participation of 12 laboratories. 
 
The relative standard deviation for repeatability (RSDr) ranged from 1.3 to 21%.  
The relative standard deviation for reproducibility (RSDR) ranged from 6.5 to 49.0%, reflecting 
HorRat values from 0.5 to 2.2 according to the Horwitz function modified by Thompson.  
However the precision was not very satisfactory (> 22% RSDR) for mass fraction levels around 
and lower of 100 µg/kg on fat basis.  
 
For an analyte content higher than 100 µg/kg, excellent precision was achieved with HorRat 
values in the range of 0.4-0.7. 
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1. Introduction  
Fatty acid esters of 3-monochloropropanediol (3-MCPDEs), 2-monochloropropanediol (2-
MCPDEs) and glycidol (GEs) are substances that are mainly generated during the refining of 
edible fats and oils, or in a domestic cooking environment [1]. They were detected in a variety 
of different foodstuffs, especially in products containing higher amounts of vegetable oils. High 
levels above 4 mg kg-1 have been reported in refined vegetable oils and various heat processed 
foods [2]. Although the information currently available on their toxicological properties and 
bioavailability is not sufficient to draw firm conclusions, great concern has been raised due to 
the carcinogenicity of their hydrolysable moieties [3]. The Scientific Panel on Contaminants in 
the Food Chain (CONTAM) of the European Food Safety Authority (EFSA) assumed a 100 % 
release of the MCPD moiety from its esters in humans through the action of gut lipases. Free 3-
MCPD is listed as a threshold genotoxic carcinogen and glycidol as probably carcinogenic to 
humans [4, 5].  
Concerns surrounding the presence of MCPDEs and GEs in many types of thermally processed 
foods have necessitated the development of analytical methods suitable for their determination 
in diverse matrices with the scope of improving overall confidence in analytical results. For 
years, the scientific community has debated whether the information on the MCPDEs and GEs 
content in oils/fats is dependent on the method used to perform the analysis [2]. 
Unfortunately, the analytical community still lacks the certified reference materials with defined 
analyte concentrations to perform trueness check. For this reason, analysts compare their 
results to data gained by other analytical methods. So far, it is not yet apparent which 
methods and conditions provide results closer to the true value.  
The EFSA report from 2013 [3] highlighted weaknesses in the analytical methods for the 
determination of 3-MCPD in different food groups and recommended to further develop and 
establish standard analytical methods for analysing 3-MCPD in its different forms with 
adequate performance parameters, in order to reduce the uncertainty in occurrence and 
exposure estimates.  
Between 2012 and 2013 three improved analytical methods for the analysis of MCPD esters 
and glycidyl esters in fats and oils have been developed. In August 2013, after a collaborative 
study with 20 participants from eight countries, the American Oil Chemists’ Society (AOCS) has 
validated and adopted the improved methods as official AOCS methods [6, 7, 8]. The methods 
are suitable for the analysis of fats and oils, and provide a valuable starting point for the 
development of methods covering the analysis of other food matrices.  
A method comparison study organized in 2012 by the Joint Research Centre (JRC) of the 
European Commission on the determination of 3- and 2- MCPD esters and glycidyl esters in 
edible oils confirmed the comparability of results obtained with different indirect analytical 
methods [9]. 
In order to gather reliable occurrence data to support the exposure assessment for the EFSA 
opinion, improved and validated analytical methods are required for the analysis of 3- and 2-
MCPD esters and glycidyl esters in the relevant food matrices. 
Consequently, EFSA requested the JRC to develop and validate in-house a robust indirect 
analytical method for determining 3- and 2-MCPD- fatty acid esters and GEs in a wide variety 
of food matrices with adequate performance parameters. It should allow the analysis of more 
than 600 food samples, covering all categories of food commodities. Methods specified by the 
AOCS for oil and fats were used as a basis for the method development and optimisation. The 
method that includes acidic transesterification of the ester forms [6] was applied with slight 
modifications as building block for the design of the Standard Operating Procedure (SOP) of the 
analytical method described here. 
The project included the performance of an ad hoc survey on specific food groups to test the 
analytical methods and to provide a minimum database on levels of 3- and 2-MCPD and 
glycidol in those food groups. The food groups addressed by the survey included in the JRC 
Project were: 
 Bread and rolls 
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 Fine bakery wares 
 Smoked fish products 
 Smoked meat products 
 Fried or roast meat (all possible types, including grilled and griddled) 
 Chips, crisps, fries and dough-based analogues (both, potato- or cereal-based) 
 Margarine 
 Infant and follow-on formulae 
The analyses of 3- and 2-MCPD covered both, those originally present in food in free form and 
those from esters of fatty acids. The analyses of glycidol were for glycidol derived from esters 
only. 
A variety of solvents were used for the extraction of 3- and 2-MCPD fatty acid esters (with or 
without GE) from food samples for indirect determination. The solvents generally need to be 
more polar than simple alkanes such as hexane for complete recovery, particularly for 3-MCPD 
monoesters. The solvents commonly used are t-butyl methyl ether or mixtures of t-butylmethyl 
ether with hexane or petroleum ether, or mixtures of hexane with diethyl ether [10, 11]. The 
inclusion of acetone is particularly useful for the extraction of MCPD fatty acid esters from dry 
infant formula [12]. 
In a collaborative trial dedicated only to the determination of 3- and 2-MCPD fatty esters, the 
BfR compared extraction methods for MCPD fatty acid esters in infant formula, sweet spread 
and chocolate cream, each containing vegetable fats, plant-based onion lard, and mayonnaise 
[12]. The collaborative trial used an extraction step based on accelerated solvent extraction 
(ASE, also known as pressurised liquid extraction, PLE) with a solvent mixture of petroleum 
ether/iso-hexane/acetone (2/2/1 v/v) using two extraction cycles at a temperature of 125 °C. 
The ASE method had very good repeatability within the laboratories and sufficient 
reproducibility between the laboratories for all of the matrices for 3- and 2-MCPD fatty esters. 
The ASE method was compared with Soxhlet extraction, which was found to be less 
reproducible, possibly due to variations in the procedures used. The ASE method was also 
compared to several cold solvent extraction methods, which exhibited poorer recovery. The 
trueness and precision were better for hot extraction methods than for cold ones, and varied 
with the type of food product analysed. Analysis of the glycidyl esters contents, however, was 
not covered by the scope of that study. 
An SOP that included the determination of glycidyl esters  was elaborated by the European 
Union Reference Laboratory for Polycyclic Aromatic Hydrocarbons (EURL PAH) of the JRC, 
based on the BfR method [12] with a small deviation during the derivatisation step. It has been 
compared in a collaborative study with four external expert laboratories in the field (Nestle, 
Federal Institute for Risk Assessment /BfR/, SGS-Germany, Hamburg University) to assess the 
performance of different analytical procedures in various food commodities. The test items 
used in this exercise consisted of five naturally contaminated samples such as smoked fish, 
waffles, infant formula, puff pastry, andolive oil. The participants were asked to use the 
method of their choice and no further requirements were imposed regarding methodology. 
In total, eight datasets for each matrix were reported to the JRC as organiser of the study. 
Their evaluation supported the assumption of an agreement of the results from the 
determination of MCPD esters and GEs in most of the tested food matrices, independent of the 
conditions applied during extraction and transesterification. The only problematic matrix 
appeared to be fish, as fish contains free 3-MCPD. This collaborative trial served as an external 
control for the reliability of the SOP, developed by JRC, in the situation of a lack of a reference 
method and reference substances for trueness evaluation.  
The SOP was applied for the analysis of more than 600 samples of breads and bread rolls, fine 
bakery wares, smoked fish and meat products, fried and roasted meat, potato-based snacks 
and fried potato products, cereal-based snacks, and margarines. All the results were reported 
to EFSA in 2014.  
In 2016 an assessment of critical steps in the above mentioned method was performed for the 
simultaneous determination of MCPDEs and GEs in the fat phase obtained from bakery and 
potato products, smoked and fried fish and meat, and other cereal products [13]. It was 
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concluded that the trueness of the measurement results is affected by the additional formation 
of 3-MBPD esters from monoacylglycerols (MAGs), which are frequently present in food. The 
overestimation of GE contents for some samples was confirmed by the comparison of results 
with data obtained by an independent analytical method (direct analysis of GE by HPLC-
MS/MS). An additional sample pre-treatment by SPE was introduced to remove MAGs from fat 
prior to the GEs conversion, while the overall method sensitivity was not significantly affected. 
Trueness of the determination of GEs by the modified analytical procedure was confirmed by 
comparison with a direct analysis of GEs. 
The derivatization of the free forms of MCPD and MBPD with PBA was evaluated in aqueous or 
organic phases, as well as the assessment of the potential impact on the accuracy of results of 
the final sample preparation step of the analytical procedure. Different commercial batches of 
PBA showed differences in solubility in a non-polar organic solvent. The PBA derivatization in 
an organic solvent did not affect the precision and the trueness of the method due to the 
isotopic standard dilution. However, the method sensitivity might be significantly compromised 
[13]. 
After submission of the results from the survey to EFSA, DG SANTE requested a collaborative 
trial for the validation of the SOP.  As such, a collaborative trail has never been conducted 
before for glycidyl esters.  
This method validation study (MVS) is aimed at evaluating the precision characteristics of an 
analytical method [Annex 10] for the determination of fatty acid esters of 3-
monochloropropanediol (3-MCPDEs), of 2-monochloropropanediol (2-MCPDEs) and of glycidol 
(GEs) in a wide variety of food products, with a fat content of more than 5 %. 
2. Method description 
After extraction by pressurised liquid extraction (PLE), acid transesterification and 
derivatisation of the released free (non-esterified) form with phenylboronic acid (PBA), the PBA 
derivatives are consecutively measured by gas chromatography-mass spectrometry (GC-MS) 
with electron ionisation (EI) in selected ion monitoring mode (SIM). Quantification of the 
analytes is carried out using 3-MCPD-ester-d5 (rac 1,2-bis-palmitoyl-3-chloropropanediol-d5), 
2-MCPD-ester-d5 (1,3-Distearoyl-2-chloro-propanediol-d5) and Gly-O-d5 (pentadeuterated 
glycidyl oleate) as internal standards. Results are expressed as free forms of 2-MCPD, 3-MCPD 
and as glycidol. The working range of the method is 25 μg kg-1 – 4 mg kg-1 for free forms of 2-
MCPD and 3-MCPD and 12.5 μg kg-1 – 2 mg kg-1 for the free form of glycidol. 
The study was designed and evaluated according to the International Union for Pure and 
Applied Chemistry (IUPAC) Harmonised Protocol [14]. Statistical analyses were performed 
along the lines of ISO 5725 [12] using the ProLab software [15]. 
3. Design of the interlaboratory validation study  
3.1 Time frame 
Table 1 provides information on the timing of the study. 
 
Table 1: Timing of the study  
 Call for expression of interest in participation 13 December 2016 
Public consultations/ derivatisation step selection until 16 January 2017 
Informing the registered participant for the final SOP to be validated 16 January 2017 
Sample dispatch for the pre-trial 08 February 2017 
Deadline for reporting results 20 March 2017 
Participants selection for the trial 04 May 2017 
Sample dispatch for the co-lab study 23 June 2017 
Deadline for collection of the results 15 August 2017 
Announcement of the results to the participants November 2017 
Final report publication December 2017 
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3.2. Invitation for participation and public consultations 
The SOP of the method to be validated was published for public consultations simultaneously 
with the call for the expression of interest.  E-mails with the information and registration link 
were sent to more than 150 contact points in Europe, Asia and America via EURL-NRL-PAH 
network, as well as to the participants in the previous collaborative trials in that field [9, 12].  
Having in mind the variations in different steps of the available methods for determination of 
MCPDEs and GEs in foodstuff, two options for the final derivatisation step of the procedure 
were proposed - in an aqueous (as it is in AOCS method) and in an organic phase (modified to 
prevent the problems encountered by some laboratories from the high PBA content in the 
aqueous phase). Depending on the number of potential participants, interested in one or 
another procedure, the launch of the respective SOP for validation by laboratories would be 
chosen after the registration phase. 
The outcome from the registration showed a slight preference to the SOP applying a 
derivatisation in organic phase (PBA in diethyl ether). As the number of registered participants 
would have not been sufficient to validate both SOPs, we asked the applicants that chose the 
SOP with aqueous derivatisation whether they are going to participate in a collaborative trial 
for the validation of a SOP with derivatisation in an organic phase. Participants were invited, on 
a voluntary basis, to provide an additional set of results obtained by applying the derivatisation 
in an aqueous phase with the intention to validate both SOPs (if feasible). 
Two comments were received from applicants, pointing out problems with PLE for the 
reproducible extraction of fat from powder IF.  As the SOP has been applied successfully to 
determine the target analyte from more than 600 food sample including 25 powder infant 
formula samples, and due to the time constrains, the organisers decided to go on with the SOP 
without making any changes.  
In total 16 applicants from NRLs, OCLs and industry in six member states agreed to participate 
in the pre-trail and to follow the SOP, suggested by the JRC (Figure 1). Fourteen had already 
previous experience with the determination of 3-MCPD- and 2-MCPD-esters in oil and fat, nine 
of them applied a similar method in routine for other food commodities as bakery products or 
confectionary, while 5 more had limited experience with additional food commodities than oil 
and fat (Figure 2). Fewer participants declared mastering of the glycidyl esters' analysis as 
concerns for the occurrence of glycidol and glycidyl esters in food and their analysis emerged 
more recently (Figure 3).   
 
Fig.1 Number of registered 
participants per country 
Fig.2  Previous experience with 
similar analysis for 3- and 2- 
MCPD esters 
Fig.3 Previous experience with 
similar analysis for glycidyl 
esters 
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3.3 Pre-trial 
Although almost all of the participants declared previous experience with similar SOPs for the 
determination of 3-MCPD- and 2-MCPD-esters and a bit less with glycidyl esters, a preliminary 
trial was conducted with the aim to familiarise the laboratories with this specific SOP method, 
to optimise instrument parameters where needed and, most importantly, to check the 
detection capability of laboratories’ instruments, given the anticipated working range. 
The pre-trial was conducted in the period January-April 2017.  
Two test samples were prepared in-house for the pre-trial - Sample A - edible oil (1 ml) and 
Sample B - infant formula (10 g). The choice of foodstuff was made based on the proposal of 
the European Commission for a Regulation of the levels of 3-MCPD esters and glycidyl esters 
only for oils and fats and infant formulae. The samples, together with 1 ml labelled standard 
mix to be used as internal standard, were dispatched in dry ice to 16 participants in the end of 
January with 6 weeks reporting deadline.  
In the course of the pre-trial other participants informed us that they were not able to obtain 
satisfactory fat recovery from their quality control samples of powdered infant formula when 
applying PLE. Upon detailed communication with those participants and exchange of samples, 
we jointly concluded that there are Infant Formulae on the market for which PLE is not suitable 
for the extraction of the entire fat. 
After the deadline only 12 datasets were submitted, 10 of which were accepted (Figure 4). One 
participant informed us about some internal problems with implementation of the methods and 
withdrew their result until further confirmation. Confirmation has not be achieved as of yet. 
Another laboratory was not able to fulfil the requirement to use PLE for the extraction of the fat 
from the different types of the food commodities and provided dataset of results obtained after 
Soxhlet extraction. Those two datasets were rejected. The rest of the results were subjected to 
robust statistics, and the resulting parameters for reproducibility are shown in Table 2.  
 
 
 
Figure 4. Participants per country for the pre-trail of the MVS. 
 
No problems were observed in the analyses of the oil test sample. Relative reproducibility 
standard deviations (RSDR) were far below truncated Horwitz, resulting in very satisfactory 
HorRat values in the range of 0.3-0.7. Similar were RSDR for 3-MCPD- and 2-MCPD-esters from 
infant formula on expressed fat base. Due to the relatively lower content and the complexity of 
the analytical procedure, RSDR for GEs was much higher. 
 9 
 
 
Table 2. Results from the pre-trial  
 
3.4 Participating Laboratories 
All 10 participants, whose results have been accepted for statistical treatment during the pre-
trail phase, were invited to participate in the collaborative trial.  
 
3.5. Test materials 
The initial plans were to include in the collaborative trial food samples representing all the 
categories addressed by the Commission Recommendation 2014/661/EU. 
Unfortunately, during the preparatory stage of the collaborative trial, the EURL-PAH 
experienced difficulties in finding suitable naturally contaminated fish/meat products on the 
market. Consequently this category of food samples was not included in the trial.  
Meanwhile, at the end of March 2017, the AOAC published a call for establishing a Working 
Group to begin standard development activities for 2- and 3-MCPD and GE in finished infant 
formula (IF) products, which triggered the decision not to include IF as matrix for the 
collaborative trial at that stage until a more robust method is suggested for powder IF.  
Recently AOAC INTERNATIONAL announced the availability of the draft standard method 
performance requirements (SMPR®) for 2- and 3-MCPD esters & Glycidyl esters (GE); invited 
method developers to submit methods for consideration and possible evaluation through the 
AOAC Official Method SM program and launched a call for experts in 2- and 3-MCPD esters & 
Glycidyl esters (GE) analysis to participate on the Expert Review Panel (ERP). The ERP will 
review and evaluate candidate methods for First and/or Final Action Official Methods of Analysis 
SM status, which is expected for be finalised during the first half of 2018.  
Table 3 summarises the test samples included in the pre-trial/trial, their sample coding and 
their corresponding food categories. 
 
 
Lab. Code 3MCPDE 2MCPDE GES 3MCPDE 2MCPDE GES IF1 FAT 3MCPDE 2MCPDE GES
µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg g/100g µg/kg µg/kg µg/kg
06 151.7 84.4 41.6 624.9 347.8 171.5 24.28 548.9 296.1 943.2
11 730 340 530 10.5 540 270 1080
03 170 79 13 610 283 46 27.9 557 270 1033
08 101 46 7.2 718 328 51 14 544 282 1093
13 216.1 99.3 26.5 777.5 357.2 95.2 27.8 659.9 360.2 867
07 35.7 13.9 3.2 713 278 64 5 563 252 981
09 163.4 87.9 48.4 649.2 349.2 192.2 25.2 513.6 272.8 937.6
14 188 88.1 84.2 709 333 318 26.4 586 283 1140
16 225 101 56 747 337 185 30.1 563 288 1140
17 166.4 71.5 75.1 650.7 279.7 293.8 25.7 533.3 323.2 911.5
– – – – – – – – – – – – – – – – – – –
Mean 163 78 39 693 323 180 22 554 286 1012.63
Target s.d. 54 24 33 63 35 136 9 28 27 111.33
Rel. SDPA 32.9% 31.1% 84.1% 9.1% 10.8% 75.4% 40.4% 5.0% 9.3% 11.0%
Rel. reproducibility s.d. 32.9% 31.1% 84.1% 9.1% 10.8% 75.4% 40.4% 5.0% 9.3% 11.0%
HORRAT 1.6 1.3 3.2 0.5 0.6 3.6 16.1 0.3 0.5 0.7
Relative classical Horwitz 
s.d.
21.0% 23.5% 26.0% 16.9% 19.0% 20.7% 2.5% 17.5% 19.3% 15.97%
Standard error 17.84 8.05 11.06 19.98 11.07 42.93 2.82 8.72 8.44 35.21
No. of laboratories after 
elimination of outliers type 
A-L except E
9 9 9 10 10 10 10 10 10 10
No. of measurement 
values and states
10 10 10 10 10 10 10 10 10 10
OilIF_Product base IF_FAT base
 10 
 
Table 3: Test items used in the pre-trial and  the trial. 
  
Food category Food item Sample code 
(a) vegetable oils and fats and derived products such as 
margarine and similar products,  
Oil  
Oil 
Fat 
Pre-trial SAMPLE 1 
SAMPLE B and O - S001 
SAMPLE C and M - S002 
(b) foods for particular nutritional uses as defined in 
Directive 2009/39/EC of the European Parliament and of the 
Council (1) and intended for infants and young 
children, including infant- and follow on formulae  
Infant formula Pre-trial SAMPLE 2 
(c)  fine bakery wares,  
 
      bread and rolls  
waffle 1 
waffle 2 
crackers 
SAMPLE E and K - S004 
SAMPLE F and I  - S005 
SAMPLE G and L - S006 
(d) canned meat (smoked) and canned fish (smoked),  Not available Not available 
(e) potato- or cereal-based snacks, other fried potato-based 
products,  
potato chips SAMPLE D and J - S003 
(f) vegetable oil containing foods and foods prepared/ 
produced with vegetable oils. 
- - 
 
3.5.1 Preparation 
The test items were prepared at JRC Geel from starting materials, acquired at a local 
supermarket. The content of MCPD esters and glycidyl esters was tested on a small subsample. 
Afterwards the materials, except the fat and oil sample, were frozen in liquid nitrogen and 
ground. The materials were sieved through a 1 mm metal sieve and homogenized. Aliquots of 
about 10 g were packed in plastic screw cap tubes and stored at –18 °C.  
The oil sample was homogenized and filled in amber glass ampoules. The fat sample was 
melted, homogenized and filled in amber crimp cap vials. 
 
3.5.2 Homogeneity and stability 
The food test samples were tested for significant inhomogeneity, according to the IUPAC 
International Harmonized Protocol for the Proficiency Testing of Analytical Chemistry 
Laboratories [14]. 
Homogeneity experiments included samples analysis of 10 samples, randomly selected along 
the filling sequence among the amber glass vials prepared for dispatch. The duplicate analyses 
were performed in random order. The test material was rated sufficiently homogenous and no 
trend was observed. Details of the homogeneity tests are given in ANNEX 6. Homogeneity for 
the samples C and M (fat) was not tested in this study, as it had been proven in a previous 
collaborative trial [9]. 
The samples were dispatched in polystyrene containers with dry ice to maintain the samples 
frozen during shipping. Laboratories were requested to store the test materials at -18 °C upon 
arrival until analysis. 
The stability of the analytes in the test materials from all different food categories was 
investigated in a detailed isochronous study, conducted by the EURL-PAHs in 2015 [16].  
Nevertheless, a short stability study was performed with the test materials included in this 
collaborative trial. Randomly selected test samples were stored at two different conditions over 
the period from dispatch of the material to the end of the submission of the results.  
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The first set of samples was stored in a freezer at recommended conditions (~ -18 °C). The 
second set of samples was stored for the whole period of the study in a deep freezer at the 
reference conditions (~ - 80 °C). After the deadline for reporting of the results had expired, all 
samples were analysed in duplicate under repeatability conditions . 
No significant difference of the analyte contents among the test samples was found (t-tests). 
Hence stability of the samples over the whole period can be assumed under the recommended 
conditions. 
 
4. Evaluation of the submitted results 
4.1 General 
Six test materials in blind duplicates, in total 12 coded samples, were dispatched to the 10 
participants, plus 1 ml labelled standard mix to be used as internal standard. The detailed SOP 
(Annex 8), instructions on handling of the samples and reporting (Annex 3), together with a 
"sample receipt form" (Annex 4) were included in the parcel as well.  
After the deadline for reporting, nine participants (from the initial ten) returned their results. 
Unfortunately one participant reported severe technical problems with the instrumentation for 
a long period, therefore not being able to provide results even after the deadline for reporting.   
The results are listed in ANNEX 7.  
Statistical evaluation of the results was carried out with a ProLab software [15], according to 
ISO 5725-2 [18] and the Collaborative Study Guidelines of AOAC for blind (unpaired) replicates 
[19]. 
These guidelines recommend assessing the results in the following manner:  
(i) visual inspection of the data for identification of irregular data (and removal of such data); 
(ii) identification of outliers using numerical statistical tests.  
Irregular or outlying data were discarded, if applicable. After evaluation of the data, the HorRat 
(Horwitz ratio) is calculated. HorRat is described for evaluation of collaborative studies. The 
HorRat is the ratio of the reproducibility relative standard deviation, expressed in percent 
(RSDR %) and the predicted reproducibility relative standard deviation, expressed in percent 
(PRSDR %) derived from the Horwitz function modified by Thompson. 
The following guidelines should be used to evaluate the assay precision [19]: 
HorRat ≤ 0.5— Method reproducibility may be in question due to lack of study 
independence, unreported averaging, or consultations. 
0.5 < HorRat ≤ 1.5 Method reproducibility as normally would be expected. 
HorRat > 1.5— Method reproducibility worse than normally expected: possible reasons 
should be critically looked at (e.g., were test samples sufficiently 
homogeneous, indefinite analyte or property?) and discussed this in the 
collaborative study report. 
HorRat > 2.0— Method reproducibility is problematic. A high HorRat may result in 
rejection of a method because it may indicate unacceptable weaknesses 
in the method or the study.  
 
4.2 Evaluation of the chromatograms 
Participants were requested to send chromatograms for the analysed samples. The study 
organiser checked them for sufficient resolution between the analyte peaks and neighbouring 
peaks. Moreover, chromatograms were checked for consistency in the retention time of the 3-
MCPD, 2-MCPD and 3-MBPD as analytes and for sufficient peak intensity.   
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4.3 Evaluation for deviations from the method and outlier check 
The first step of the data evaluation was the identification of laboratories that deviated 
significantly from the analytical protocol either intentionally or unintentionally. A dedicated 
questionnaire had to be filled in by the participants in order to enable the organisers of the 
study to identify major deviations from the analytical procedure (Annex 5). Data obtained by 
the application of such procedures would be considered incompatible with data generated by 
the tested procedure. Such discordant data have to be removed from the data set according to 
ISO 5725-2. Thanks to the pre-trail step, such deviating datasets were not detected. 
 
Evaluating the answers from the questionnaire, few other slight deviations were identified. 
However the organisers do not consider them as influencing the outcome:  
- in 11.2 from SOP - use of polyacrylic acid (<1000 µm) and sand (48 - 150 mesh);  
- in 8.10 from SOP - glass fibre filters instead of cellulose; 
- in 11.3 from SOP - evaporation of solvent after PLE over night at 30 °C; 
- in 11.4 point 8 from SOP - during the extraction with ethyl acetate, the phase separation was 
difficult to be seen; consequently  addition of a small amount of a dye (10 µl Cochenille red A - 
E124) to each sample/standard. 
 
The results from 9 participants underwent statistical data analysis (Grubbs tests applied to 
single suspects mean measurement values and Cochran test applied to any suspect 
repeatability variances). Due to the low number of datasets (9), maximum 1 outlier per test 
item could have been removed. Eight individual Cochran outliers were removed from 8 
datasets, before calculation of the performance parameters.  
 
4.4 Evaluation of the results - precision parameters 
 
Statistical analyses were performed along the lines of ISO 5725-2 [18] with the help of the 
PROLab® software [15] and the outcome is presented on Table 4.  
 
The precision data for most of the analyte-matrix combinations (15/18 on fat basis and 12/14 
on product basis) were excellent.  
 
With only one exception (GE in sample S005) the repeatability wasin all the cases satisfactory 
(1.3-10%) at the validated mass fraction levels.  
 
The reproducibility standard deviations were lower than the truncated Horwitz prediction, 
resulting in outstanding HorRat values around 0.4-0.7. Only for the glycidyl esters' content in 
two test materials (S004 and S005) expressed on fat basis as well as on product basis, the 
HorRat values were close to 2 with relative standard deviations of 42-49% (Figure 4).  
 
The mean values for the analyte (3-MBPD) in those two test materials were 79.1 μg kg-1 and 
110.3 μg kg-1 respectively, falling well in the range of LOQs reported by most of the 
participants (Figure 5). We attribute this finding to the fact that some of the participants did 
not tune their instruments for higher sensitivity, as 100 μg kg-1 is the requested LOQ laid down 
in the Commission Recommendation for monitoring [20]. The assumption is supported by the 
detailed evaluation of the chromatograms for sufficient peak intensity, where we observed 
rather low intensity of the peaks for 3-MBPD in samples E, F, K and I.  
To our knowledge this is the first collaborative trial for the determination of the 3-MCPD- and 
2-MCPD esters as well as glycidyl esters, including test materials with very low contents of the 
analytes. The outcome revealed that content in the range of 100 μg kg-1 and lower in the fat 
remains challenging to be well reproducible in different laboratories.   
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Table 4a. Performance parameter for precision on fat base 
 
 
 
 
Table 4b. Performance parameter for precision on product base 
 
 
 
 
 
 
S001 S002 S003 S004 S005 S006 S001 S002 S003 S004 S005 S006 S001 S002 S003 S004 S005 S006
Unit µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg
Method ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2
No. of labs submitted results 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9
Type Grubb outliers
Type Cochran outliers 1 1 1 1 1 1
No. of lab after elimination 9 8 9 9 9 9 8 9 9 9 9 8 8 8 8 9 9 9
Mean 283.2 285.3 1677.7 438.5 530 1176.9 569.5 724.7 4187.1 971.8 1095.3 2542.6 994.8 1455.2 265.8 79.1 110.3 2277.9
Target s.d. 54.8 55.1 248.3 79.4 93.3 183.7 99.2 121.7 540 156.1 172.8 353.4 159.3 220 51.9 17.4 24.3 321.9
Reproducibility s.d. 32.6 68.5 122.7 43 62.6 103.3 50.2 62.5 288.7 81.2 121.4 166.1 75.2 104.7 56.7 33.7 51.5 156.4
Repeatability s.d. 32.6 9.8 73.8 17.2 44.4 29.1 12.7 18.5 149.8 40.2 90.6 33.8 42.6 104.7 26.6 6.6 19.3 113.2
tr-Horwitz 19.3% 19.3% 14.8% 18.1% 17.6% 15.6% 17.4% 16.8% 12.9% 16.1% 15.8% 13.9% 16.0% 15.1% 19.5% 22.0% 22.0% 14.1%
Relative reproducibility s.d. 11.5% 14.4% 7.3% 9.8% 11.8% 8.8% 8.8% 8.6% 6.9% 8.4% 11.1% 6.5% 7.6% 8.6% 21.3% 42.7% 46.7% 6.9%
Rel. repeatability s.d. 11.5% 7.8% 4.4% 3.9% 8.4% 2.5% 2.2% 2.6% 3.6% 4.1% 8.3% 1.3% 4.3% 6.7% 10.0% 8.3% 17.5% 5.0%
Horrat 0.6 0.7 0.5 0.5 0.7 0.6 0.5 0.5 0.5 0.5 0.7 0.5 0.5 0.6 1.1 1.9 2.1 0.5
2-MCPDEs fat base 3-MCPDEs fat base GEs fat base
S003 S004 S005 S006 S003 S004 S005 S006 S003 S004 S005 S006
Unit µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg
Method ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2
No. of labs submitted results 9 9 9 9 9 9 9 9 9 9 9 9
Type Grubb outliers
Type Cochran outliers 1 1 1 1
No. of lab after elimination 8 9 8 9 9 9 8 9 8 9 9 9
Mean 456.2 113.9 141.1 135.2 1133.9 253 292.7 289.9 71.9 20.5 28.2 261.6
Target s.d. 82.1 25.1 30.3 29.2 178 49.8 56.3 55.9 15.8 4.5 6.2 51.2
Reproducibility s.d. 35.8 10.9 13.4 12.8 80.4 23.5 22.7 22 15 8.7 13.8 20
Repeatability s.d. 9.5 4.1 2.9 2.6 34.3 9.1 4.8 5.9 7.4 1.5 6.1 9.5
tr-Horwitz 18.0% 22.0% 21.5% 21.6% 15.7% 19.7% 19.3% 19.3% 22.0% 22.0% 22.0% 19.6%
Relative reproducibility s.d. 7.9% 9.5% 11.2% 9.5% 7.1% 9.3% 9.2% 7.6% 20.8% 42.5% 49.0% 7.6%
Rel. repeatability s.d. 2.1% 3.6% 6.2% 1.9% 3.0% 3.6% 4.7% 2.0% 10.3% 7.5% 21.6% 3.6%
Horrat 0.4 0.4 0.5 0.4 0.5 0.5 0.5 0.4 0.9 1.9 2.2 0.4
2-MCPDEs product base 3-MCPDEs product base GEs product base
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Figure 4. RSDr (black line), RSDR (blue line) and tr-Horwitz (red line) depending on the level 
of content of the analyte, expressed on fat base 
 
 
 
 
Figure 5. LOQs reported by the participants and 3-MBPD content in samples S004 and S005 
(red lines). 
 
5. Conclusions  
 
Within this collaborative study for 3-MCPD-, 2-MCPD esters and glycidyl esters in thermally 
processed food, a standard operation procedure, prescribed by the EURL-PAH and Process 
Contaminants, based on acid transesterification and derivatization in organic phase, was tested 
by several laboratories from Europe, Asia and USA. The following is concluded: 
 The method is suitable for the determination of 3-MCPD-, 2-MCPD esters and glycidyl 
esters in oil and fat, waffles, chips and crackers in the range of 250-2500 µg kg-1 fat 
corresponding to 100-1100 µg kg-1 product with HorRat values of 0.5-1.0; 
 The determination of content lower and around 100 µg kg-1 fat still remains challenging 
with HorRat values of 1.9-2.2. This range may be tolerated as the range is close to the 
LOQ for most of the laboratories.  
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List of abbreviations and definitions 
 
DG SANTE Directorate General Health and Food Safety 
EC   European Commission 
EU   European Union 
EFSA  European Food Safety Autority 
EURL-PAHs European Union Reference Laboratory for Polycyclic Aromatic Hydrocarbons 
GC-MS/MS Gas chromatography with tandem mass spectrometry 
ILC   Interlaboratory comparison  
ISO   International Organization for Standardization 
JRC   Joint Research Centre 
LC-MS/MS Liquid chromatography with tandem mass spectrometry 
LOD   Limit of Detection 
LOQ   Limit of Quantification 
MRL   Maximum residue level 
NRL   National Reference Laboratory 
OCL   Official food control laboratory 
SOP  Standard Operating Procedure 
3-MCPDEs fatty acid esters of 3-monochloropropane-1,2-diol 
2-MCPDEs fatty acid esters of 2-monochloropropane-1,2-diol 
GEs  fatty acid esters of glycidol 
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ANNEX 1: Call for expression of interest 
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ANNEX 2: Public consultation survey 
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ANNEX 3: Instructions to participants 
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ANNEX 4. "Sample Receipt" Form 
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ANNEX 5. Questionnaire & Answers from participants  
Questions, sent to the participants in the pre-trail  
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Answers from the participants in the pre-trial 
 
 
 Lab Code 1. Lab 
experience 
MCPDEs 
2. Lab 
experience GEs 
3. Samples per 
year 
4. Accreditation 5. Analyst 
experience. 
6. Instructions 7. If NO, improvements 8. ProLab/RingDat 
interface 
9. Problems? 10. If YES, what kind 
of problems? 
LC0003 5 3 20  Yes, for MCPD esters and GEs in oil/fat:    3 Yes   Good No   
LC0005 2 years 2 years 250 No 2 years Yes   effective No   
LC0006 10 7 100 Yes, for MCPD esters in oil/fat:    
Yes, for MCPD esters and GEs in oil/fat:    
Yes, for MCPD esters in foodstuff:    
Yes, for MCPD esters and GEs in foodstuff:    
 
5 Yes   uncomfortable usage No   
LC0007 since 2009 since 2009 200 Yes, for MCPD esters in oil/fat:   
Yes, for MCPD esters and GEs in oil/fat:    
Yes, for MCPD esters in foodstuff:   
Yes, for MCPD esters and GEs in foodstuff:    
5 years Yes   practical No   
LC0008 5 2 100 Yes, for MCPD esters in oil/fat:    
Yes, for MCPD esters and GEs in oil/fat:    
Yes, for MCPD esters in foodstuff:    
Yes, for MCPD esters and GEs in foodstuff:    
5 Yes   LOQ and LOD of fat 
content make no 
sense 
No   
LC0009 since 2007 since 2010 > 3000 Yes, for MCPD esters and GEs in foodstuff:   > 5 Yes     Yes cannot open it, on 
network 
LC0011 2005 2010 2600 in 2016  Yes, for MCPD esters in foodstuff:    12 years Yes   Yes Trying to save the data, 
everything disappeared; 
Consuming a lot of time; 
Error in the table F-
MCPD on the basis 
LC0013 2 1 10-20 Yes, for MCPD esters in oil/fat:   
Yes, for MCPD esters and GEs in oil/fat:    
Yes, for MCPD esters in foodstuff:    
1-2 Yes   difficult to use 
because of problems 
with opening the 
program 
Yes McAfee Virenscanner did 
block opening the 
program 
LC0014 10 years 10 years 30 samples No:  1 years Yes   no problem No   
LC0016 14 years 9 <100 Yes, for MCPD esters in oil/fat:   
Yes, for MCPD esters in foodstuff:    
10 Yes N/A Good No N/A 
LC0017 6 6 300 No:  2.5 No The instructions did not 
define "MU (abs)" (on the 
measured values tab).   
OK No   
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 Lab Code 11. Any other 
comments 
12. Method 
description 
13. If NO, 
improvements 
14. Able to 
follow the 
method 
15. If NO, deviations 16. Problems 
during 
analysis 
17. If YES, 
what/were 
18. Analytical 
process 
splitted? 
19. 
Abnormalities 
noticed 
20. If YES, please 
describe 
21.Familiar 
with steps 
22. If NO, please describe 
LC0003 The proposed 
limits are expres-
sed in mg/kg. 
Yes   No Insufficient IS solution to 
prepare the working 
standards as per SOP. 
Yes Qualifier ion for GEs, 
neither 146 nor 147 is 
suitable at low levels. 
No No   Yes   
LC0005   Yes   No 11.3 we did NOT perform the 
PLE (we do not have this equip-
ment). We used the same sol-
vents but we extracted with 
soxhlet. For that reason we 
only report the results in the 
extracted oil and not in the 
product.  
Yes The PBA did not dissolve 
for 100% in di-
ethylether. Although 
the reaction seems to 
be good. 
yes preparation 
and 
instrumental 
were split 
No   No 11.3 we did NOT perform the 
PLE (we do not have this equip-
ment). We used the same sol-
vents but we extracted with 
soxhlet. For that reason we only 
report the results in the extra-
cted oil and not in the product.  
LC0006   Yes   Yes GC-MS method better 
voluntary 
Yes s. our control material no No   Yes   
LC0007   Yes   Yes   No   No No   Yes   
LC0008 11.4. 2-4 no SPE 
carried out //  
Yes   Yes   No   no No   Yes   
LC0009  Yes  No ASE Extraction for IF: use 
Extrelut for Sand ; and n-
Hexane for iso-Hexane 
No  1 No  Yes   
LC0011   Yes    Yes  Yes ASE causes 
discoloration and an 
aqueous phase; 
Method does not work 
for our in-house 
1 technician 
analysing and 
calculation, 1 
maintenance 
team 
Yes Different, unusual 
slope for the GE 
Yes  
LC0013   Yes   Yes   Yes Phase separation (ethyl 
acetate phase) at step 
11.4 / 8. , addition of 
dye necessary (10µl 
cochenille red) 
yes No   No 11.4 step 2-7 
LC0014   Yes   No used polyacrylic acid 
(ЃЃ<1000um),Sand 20Ѓ-35 
mesh 
No   No No   Yes   
LC0016   Yes N/A Yes N/A Yes For both samples: SOP 
11.4 point 8, The volume 
of EtOAc was increased to 
3 x 1 ml; SOP 11.4 point 9, 
The solubility of PBA in 
Et2O was poor. We 
prepared and used (300 
l) a solution of PBA in 
EtOAc  (0.2 g PBA  in 10  
ml EtOAc) 
No No N/A Yes   
LC0017   Yes   Yes   No   No Yes The 3-MBPD qualifier 
ion (m/z 174) was not 
present for any 
sample.  However, we 
were able to quantify 
using m/z 240. 
No We typically run a direct method 
in our laboratory, so the 
indirect methods are somewhat 
unfamiliar in practice.  However, 
we are fully knowledgeable of 
the techniques used. 
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 Lab Code 23. Overnight 
stops 
24. If YES, for 
which samples 
25. Calibration 26. Date 
cal.stand.sol. 
preparation 
27. Date 
oil 
28. Date 
IF 
29. Sequence 30. Signal 
integration 
mode 
31. Intergaration 32. Re-integration 33. Any other information 
LC0003 No   Supplier LGC, 
manufacturer 
TRC 
Individual 
23/01/2017, 
intermediate 
14/02/2017 
working stds 
27/02/2017. 
2/17/2028 2/17/2027 Yes Automatic 
with 
verification 
valley to valley 
(MassHunter agile 
2) 
Majority particularly 
qual ions for GEs. 
  
LC0005 No   TRC: Toronto 
Research 
Chemicals 
2/06/2017 3/16/2017 3/16/2017 yes Automatic horizontal baseline 0 M(u) LOD and LOQ for this method unknown, method not validated 
LC0006 Yes 1) after ASE 
evaporation  
2) after SPE  
3) Transesterification 
TRC 16.02.2017 22.02.2017 22.02.2017 yes Automatic 
with 
verification 
valley-to-valley 0 Why using amber vials? Is rinsing of the vial at step 11.4.3/4 
possible? Please specify the amount of Na2SO4. There is a wrong 
m/z for glycidyl in the method protocol (174 instead of 147). We 
used our own GC-MS method. We use Ottawa sand as fill material 
(20-30mesh), because the use of material with a higher mesh 
should be avoided according to our ASE manual. 
LC0007 No   Toronto 
Research 
Chemicals 
20.02.2017 22.02.2017 22.02.2017 Yes Automatic 
with 
verification 
horizontal baseline 50 % (including the 
chromatograms for 
the calibration 
standards) 
The fat content in IF only determined by weighing the PLE-extract. 
The LODs and LOQs for Esters in IF are only calculated based on fat 
content. 
LC0008 No   Chiron 01.03.2017 06.03.2017 06.03.2017 yes Automatic 
with 
verification 
horizontal baseline 0 The title is unclear, better ".....3-MCPD-, 2-MCPD- and ....." (with 
hyphen); it would be useful to receive  native  check standards 
LC0009 Yes Acidic 
transesterification 
for 16 h  
TRC 28.02.17 7/3/2017 7/3/2017 yes Automatic 
with 
verification 
MassHunter  0 ; only for the 
prepared Blank 
  
LC0011 1  TRC Stock solution 
Nov 2016, 
working sol. 
Feb 2017 
05.04.2017 05.04.2017 yes 3 Baseline CAL O all analytes + 
3 additional 
chromatograms 
FAPAS 2646 and FAPAS 2649 as reference material included; 
If higher fat content with in- 
LC0013 Yes all samples / 11.4 
step 6 
Biozol 
Diagnostics / EQ 
Laboratories 
GmbH 
all prepared 
new in 
February 2017 
15.03.2017 15.03.2017 yes Automatic 
with 
verification 
horizontal baseline 
(mainly) 
about 2   
LC0014 Yes Acidic 
transesterification 
Wako, tronto 
research 
13/03/2017 3/14/2017 3/14/2017 YES Automatic horizontal baseline 0 No 
LC0016 No N/A TRC 06/01/2017 3/15/2017 3/15/2017 Yes Manual N/A N/A   
LC0017 No   Toronto 
Research 
Chemicals 
03/16/2017 3/16/2017 3/16/2017 Yes Automatic 
with 
verification 
Horizontal Baseline 12 As discussed via email the PLE procedure does not work for any U.S. 
formulas, but did work for the formula sample supplied in the pre-
trial. In addition, the samples were initially prepared and analyzed 
using Gly-Ol (instead of Gly-P).  The 3-MPBD results using  Gly-Ol were 
inaccurate.  The calibration curve samples were inconsistent and the 
concentrations for the oil and infant formula samples were very high, 
well outside the upper limit of the calibration curve.  Using Gly-P 
produced an excellent calibration curve and 3-MBPD concentrations 
for the oil and infant formula samples that were very reasonable. 
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Questions, sent to the participants in the trail 
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Answers from the participants in the trial 
 
Lab Code 1. Method description 2. Able to follow 
the method 
3. Problems during analysis 4. Abnormalities noticed 5. Familiar 
with steps 
6. Any other information 7. Analytical 
process 
splitted? 
8. Overnight stops 
LC0003 YES YES Standards prepared as directed in 
protocol, Samples D & J over ~20% 
calibration range for 3-MCPDE. Sample 
L ~5% over calibration range. 
Chromatographic interference for sample M 
for both 2-MCPDE and d5-2-MCPDE. 
YES We found it necessary to filter 
the isooctane extract (we use 
Spin-X centrifuge filters) to 
prevent GC syringe needle 
blockage. 
NO YES 
LC0006 YES 8.10 Glass fibre filters 
instead of Cellulose, 
11.3  Evaporation of 
Solvent after PLE over 
night at 30°C 
NO NO YES 6.1.16. mesh should not be 
higher than 20-30 according 
to  the manufacturer of the 
PLE (ASE). 8.1. Why using 
amber glass? 
NO YES 
LC0007 Yes Yes Not during this RV, but sometimes we 
can´t analyse the content of GE, 
because there is neither a signal for GE 
nor for the d-GE (ISTD). We do not 
know exactly the reason for this 
problem. Maybe there is a malfunction 
during the step of bromination. 
No Yes All Samples were also 
measured in MRM-Mode (2-
MCPDE 196.0->104.0; 3-
MCPDE 196.0->147.0; GE 
240.0 ->147.2). The results are 
comparable with the 
transmitted results (SIM-
Mode). 
No No. Samples B, C, M, and 
O are analysed in a 
sequence w ith a separate 
calibration. Samples D, E, 
F, G, I, J, K, and L are 
analysed in a sequence w 
ith a separate calibration. 
LC0008 Yes Yes No No Yes Ion 240 for MPBD No Yes 
LC0009 yes yes For MBPD m/z 240 is reported, because 
of blank problems on 242., But the 
results for 240 after blank 
compensation are also available 
No Yes.  The first removal of 
Ethylacetat Volume 600 µl 
was tricky 
Only one 
person for the 
whole process 
Two Sequences with two 
calibrations. One for oil 
samples and one for other 
food products 
LC0011 Yes. Yes. No problems, some chromatograms not 
perfect. 
No. We normally do 
not use ASE. 
We perform 
AOCS 29a; fat 
extraction by 
Röse-Gottlieb 
(Mojonnier). 
Detection works for GCMSMS 
also (in-house Method) 
1 Person Yes. 
LC0013 yes yes yes, 11.4 point 8 Extractiion with ethyl 
acetate: The phase separation was 
difficult to be seen; that's why we 
added a small amount of a dye (10µl 
Cochenille red A - E124) to each 
sample/standard 
No Yes   Yes, Sample 
praparation 
Person1/ 
Instrumental 
Analysis 
Person2 
No, 2 sequences with 
separate calibrations : 
B,C,M,O,D,E and 
F,G,I,J,K,L resp.  
LC0014 yes. no. In 11.2., I used 
Polyacrylic acid 
(<1000um) and Sand 
(48 - 150 mesh) 
no. no. yes. Ions (m/z 196 and 201) were 
used for 3-MCPD and 3-
MCPD-d5 quantification, 
because m/z 147 baseline 
abundance was too high. 
no. yes. 
LC0016 Would recommend supplying 
both ISTD and mixed calibration 
solutions to avoid uncertainties 
associated with standards 
prepared by different labs & 
chemicals from different sources. 
Yes No No Yes   Single analyst All sample analysed on 
one sequence 
 
 
 
  
 30 
 
 
Lab Code 9. Signal integration mode 10. Integration 
setting 
11. Re-integration 12. Calibrant source 13. LOQ in fat/fat 
extract 
14. Chromatographic 
injection date 
15. Sample preparation date 
LC0003 AUTOMATICALLY with manual 
corrections of intergration. 
Agilent MassHunter 
Agile2 
All TRC (supplier LGC) 3-MCPDE 60µg/kg, 2-
MCPDE 70µg/kg and GE 
80µg/kg 
06/07/2017 PLE extractions carried out 03/07/2017, 
bromination & hydrolysis carried out 
05/07/2017, derivatisation 06/07/2017. 
LC0006 Automatically with visually 
check 
valley-to-valley   TRC Canada 2-MCPDE 5µg/kg, 3-MCPDE 
and GE 10µg/kg 
06.07.2017 PLE: 03.07. SPE 04.07. Glycidyl 
conversion and transesterification 05.07. 
end of preparation 06.07.17 
LC0007 Automatically w ith visual check Horizontal baseline more than 50 % Toronto Research Chemicals LOQ = 100 ìg/kg fat (for the 
3 analytes in all samples) 
07.07.2017 (B, C, M, and O); 
18.07.2017 (D, E, F, G, I, J, K, 
and L) 
04.07.-07.07.2017 (B, C, M, and O); 
12.07.-17.07.2017 (D, E, F, G, I, J, K, and 
L) 
LC0008 automatically with visual 
checking 
horizontal baseline all chromatogramms have 
been checked/corrected 
manually 
Chiron Norway 30 µg/kg 7/5/2017 7/3 - 7/5/2017 
LC0009 Integration is automatically and 
checked for correct integration 
settings masshaunter 
default 
blank samples need to be 
corrected native, but most are 
correct integrated 
Toronto Research Chemicals 
TRC 
LOQ-3MCPD [147]=100 
µg/kg  ; LOQ 2MCPD [196]= 
100 µg/kg; LOQ MBPD 
[240]= 100 µg/kg 
28.07.17 Food samples ; Oil 
samples 15.7.17 
26.07.17 first Part; acidic 
transesterfication over night_27.07.17 
second Part- for food samples / Oil 
samples 11 and 12.07.17 preparation  
LC0011 Automatically + visually checked. valley vallley 
horizontal 
GCMS: 7 of 396;  GCMSMS: 12 
of 882  
TRC 0.10 mg/kg result referring 
to fat/oil  for all analytes 
27th July ASE: 24th July; Analysis: 25th+26th July; 
GCMSMS: 27th July; Calculation: 31st 
July 
LC0013 Automatically with visually 
check of the correctness of 
intergration 
integration of the 
Agilent MassHunter 
Quantitative Analysis 
Software 
  Biozol Diagnostics / EQ 
Laboratories GmbH 
LOQ : 90µg/kg for MCPDE's 
and 60µg/kg for GE 
same day after finishing 
sample preparation 
  
LC0014 Automatically. yes. Horizontal baseline. 0 Wako Pure Chemical 
Industries, Ltd.  
I didn't calculate LOQ. 26/07/2017   
LC0016 Manual N/A N/A Labelled / unlabelled 3MCPDE 
from ICT Prague, Czech 
Republic; All other calibrants 
from TRC Canada. 
LOQs for all samples: 
3MCPDE, 22 µg/kg fat; 
2MCPDE, 12 µg/kg fat;  
GES, 23 µg/kg fat 
09-10/08/2017 N/A 
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ANNEX 6: Homogeneity  
 
Mass fractions  given here may be different from the consensus values of results of 
participants. These are rough estimates obtained with other calibration solutions. All data 
below is given in [µg/kg]. 
 
Sample B and O (oil) 
Homogeneity  
according to IUPAC 
Analyte 
3-MCPD 2-MCPD 3-MBPD 
Mean 0.47 0.26 1.02 
ˆ  0.082 0.050 0.163 
σ2all 0.003 0.001 0.005 
σ2an 0.025 0.015 0.049 
critical value 
(F1 σ
2
all + F2 σ
2
an) 
0.0042 0.0012 0.009 
σ2sam  0.0008 0 0 
σ2sam < critical Passed Passed Passed 
 
 
Sample D and J (potato chips) 
Homogeneity  
according to IUPAC 
Analyte 
3-MCPD 2-MCPD 3-MBPD 
Mean 4.24 1.88 0.32 
ˆ  0.547 0.278 0.061 
σ2all 0.032 0.008 0.003 
σ2an 0.164 0.083 0.018 
critical value 
(F1 σ
2
all + F2 σ
2
an) 
0.083 0.021 0.003 
σ2sam  0.036 0.008 0.001 
σ2sam < critical Passed Passed Passed 
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Sample E and K (waffle 1) 
Homogeneity  
according to IUPAC 
Analyte 
3-MCPD 2-MCPD 3-MBPD 
Mean 0.72 0.45 0.11 
ˆ  0.116 0.081 0.023 
σ2all 0.005 0.001 0.001 
σ2an 0.035 0.024 0.007 
critical value 
(F1 σ
2
all + F2 σ
2
an) 
0.008 0.0017 0.001 
σ2sam  0 0.0004 0 
σ2sam < critical Passed Passed Passed 
 
 
 
Sample F and I (waffle 2) 
Homogeneity  
according to IUPAC 
Analyte 
3-MCPD 2-MCPD 3-MBPD 
Mean 0.95 0.54 0.07 
ˆ  0.150 0.095 0.016 
σ2all 0.003 0.001 0.001 
σ2an 0.045 0.029 0.005 
critical value 
(F1 σ
2
all + F2 σ
2
an) 
0.007 0.002 0.0004 
σ2sam  0.001 0.0001 0.0001 
σ2sam < critical Passed Passed Passed 
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Sample G and l (cracker) 
Homogeneity  
according to IUPAC 
Analyte 
3-MCPD 2-MCPD 3-MBPD 
Mean 2.54 1.16 2.63 
ˆ  0.353 0.181 0.372 
σ2all 0.190 0.012 0.056 
σ2an 0.106 0.054 0.112 
critical value 
(F1 σ
2
all + F2 σ
2
an) 
0.213 0.018 0.080 
σ2sam  0 0.003 0.006 
σ2sam < critical Passed Passed Passed 
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ANNEX 7: Reported results  
 
 
 
 
 
S001 S002 S003 S004 S005 S006 S001 S002 S003 S004 S005 S006 S001 S002 S003 S004 S005 S006
Unit µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg
LC0003 274.0 223 1771.5 415 479 1181 638.5 773 4308.5 1019.5 1131.5 2669 1490 1430.5 299 71 95.5 2267
LC0006 288.0 295.4 1777.7 454.4 536.6 1243.3 505.8 619.9 3665.8 851.5 911.3 2210.1 1012 1499.4 270.4 90.6 158.3 2377.6
LC0007 274.5 337.5 1627 391 502 1113.5 584 743.5 4289 1010.5 1091 2498 968.5 1416.5 211 29.5 48.5 2385.5
LC0008 282.0 273 1714 431.5 541 1172.5 597 711.5 4283 1025.5 1167.5 2594 1016.5 1566.5 234.5 35 67.5 2430
LC0009 282.4 118.7 1626.2 476.4 590 1241.1 540.8 659.6 4589.3 1001.4 1124.1 2776.2 881.6 1237.8 278.8 77.7 110.1 2094.1
LC0011 259.0 268 1500.5 373.5 457.5 1004 605.5 749.5 4318.5 940.5 1096.5 2531.5 1129.5 1512.5 369 105.5 205.5 2384.5
LC0013 271.3 259.8 1535.8 435.4 483.4 1057.8 499.3 817.5 3911.9 865.7 971.8 1284.5 966.2 1548.7 261.4 66.6 87.5 2319.6
LC0014 295.5 294 1815 467.5 561.5 1290 585 688.5 4245 952 1100 2570 990 936 202 72.6 78.8 2165
LC0016 322.0 331.5 1732 501.5 619 1289 645.5 759.5 4073 1080 1264 2492 994.5 1430 558.5 141.5 141 2078
LC0017 not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested
– – – – – – – – – – – – – – – – – – –
Method ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2
2-MCPDEs fat base 3-MCPDEs fat base GEs fat base
S003 S004 S005 S006 S003 S004 S005 S006 S003 S004 S005 S006 S003 S004 S005 S006
Unit µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg µg/kg g/100g g/100g g/100g g/100g
LC0003 481.5 107 127 134.5 1171 263.5 300 303.5 81.5 18.5 25 257.5 27.2 25.8 26.5 11.4
LC0006 485.5 118.8 143.3 141.8 1001.1 222.6 243.4 252.2 73.8 23.7 42.4 271.3 27.3 26.2 26.7 11.4
LC0007 439.3 105.2 134.1 127.9 1158.1 271.6 291.3 287.1 57 7.9 12.9 273.9 27 26.9 26.7 11.5
LC0008 457.5 114 145.5 144 1143.5 270.5 315.5 318.5 62.5 9 18 298 26.7 26.4 27 12.3
LC0009 450.9 125.7 154.8 141.9 1273 264.3 294.9 317.5 77.3 20.5 28.9 239.6 27.8 26.4 26.3 11.4
LC0011 395.5 97.5 116.5 112 1139 246 280 282.5 97.5 27.5 52.5 266 26.4 26.2 25.6 11.2
LC0013 413.9 107.2 90.5 120.1 1053.7 213.6 183.7 268.5 70.6 16.5 17.3 263.1 26.9 24.7 17.9 11.3
LC0014 494.5 121 147 145.5 1160 246.5 288.5 291 55.1 18.8 20.7 245 27.3 25.9 26.2 11.4
LC0016 470.5 129 160.5 149 1106 278 328 288 151.5 36.5 36.5 240 27.1 25.7 25.9 11.6
LC0017 not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not tested not 
tested
not tested not tested not tested
– – – – – – – – – – – – – – – – –
Method ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-2 ISO 5725-
2
ISO 5725-2 ISO 5725-2 ISO 5725-2
fat content2-MCPDEs product base 3-MCPDEs product base GEs product base
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ANNEX 8:  
Standard Operating Procedure (as provided to participants) 
 
 
 EUROPEAN COMMISSION 
JOINT RESEARCH CENTRE 
 
Directorate F – Health, Consumers & Reference Materials  
Food & Feed Compliance (F.5)  
 
 
Standard Operating Procedure for the Simultaneous Determination of         
3-MCPD, 2-MCPD and Glycidyl Fatty Acid Esters in Various Food Matrices by 
Derivatisation in Organic Phase 
 
 
In-house validated by the EC-JRC 
2016 
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1. SCOPE AND APPLICATION 
This standard operating procedure (SOP) specifies an indirect method for the simultaneous 
determination of fatty acid esters of 2-Chloro-1,3-propandiol (2-MCPD), 3-Chloro-1,2-
propandiol (3-MCPD) and of glycidol in a wide variety of food products, with a fat content of 
more than 5 %, after extraction by pressurised liquid extraction (PLE), acid transesterification 
and derivatisation of the released free (non-esterified) form with phenylboronic acid (PBA). 
The PBA derivatives are consecutively measured by gas chromatography mass 
spectrometry (GC-MS) with electron ionisation (EI) in selected ion monitoring mode (SIM). 
Quantification of the analytes is carried out using 3-MCPD-ester-d5 (rac 1,2-bis-palmitoyl-3-
chloropropanediol-d5), 2-MCPD-ester-d5 (1,3-Distearoyl-2-chloropropanediol-d5) and Gly-O-
d5 (pentadeuterated glycidyl oleate) as internal standards. Results are expressed as free 
forms of 2-MCPD, 3-MCPD and as glycidol. The working range of the method is 25 μg kg-1 – 
4 mg kg-1 for free forms of 2-MCPD and 3-MCPD and 12.5 μg kg-1 – 2 mg kg-1 for free form of 
glycidol. The method was applied for quantification of the three groups of analytes in eight 
different food categories including: a) bread and rolls, b) fine bakery wares, c) smoked fish 
products, d) fried and roasted meat; e) potato based snacks and fried potato products, f) 
cereal-based snacks, and g) margarines 
2. PRINCIPLE 
The test sample is immersed in liquid nitrogen and then grinded and homogenized, by 
means of a laboratory grinder or mortar and pestle, to a fine homogeneous powder. A test 
portion (5 g) is mixed with polyacrylate (5 g) and sand (15 g) and transferred into the 
extraction cell. The fat fraction is then extracted with tert-butyl methyl ether (tBME) by 
pressurised liquid extraction at a temperature of 40 °C. Then the organic extract is 
evaporated until constant weight is reached. The extracted amount of fat is determined 
gravimetrically. An aliquot of the fat extract (100 ± 5 mg) is dissolved in anhydrous 
tetrahydrofuran and mixed with internal standards (rac 1,2-bis-palmitoyl-3-chloropropanediol-
d5, 1,3-distearoyl-2-chloropropanediol-d5 and pentadeuterated glycidyl oleate). Olive oil and 
margarines, consisting mostly of lipids, are directly spiked with stable isotope labelled 
internal standards and vortex-mixed with anhydrous tetrahydrofuran. A solid-phase extraction 
is performed afterwards in case of presence of partial acylglycerols, in particular MAGs. 
Glycidyl esters are firstly converted into 3-monobromopropanediol (3-MBPD) monoesters in 
an acidic solution of sodium bromide. In the next step ester-bound analytes are 
transesterified with methanol in acidic medium. The transesterification is stopped by 
saturated sodium hydrogen carbonate solution. Methanol is then evaporated under a 
nitrogen stream at 40 °C and aqueous ammonium sulphate solution is added. Thereafter, the 
sample is defatted with n-hexane and the released free MCPD and glycidol are extracted 
with ethyl acetate and derivatised with phenylboronic acid. The samples is evaporated to 
dryness and re-dissolved in isooctane prior to GC-MS analysis. 
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Injection is performed in pulsed splitless mode. The chromatographic separation is obtained 
on a 5% diphenyl, 95% dimethyl polysiloxane column (30 m x 0.25 mm internal diameter and 
0.25 µm film thickness capillary column). The analytes are ionised by electron ionization (EI) 
at 70 eV. The target analytes are recorded in Single Ion Monitoring (SIM) mode, and 
quantified by using the isotopically labelled internal standards.  
The system is calibrated with MCPD esters and glycidyl esters, which are subjected to 
transesterification and derivatisation prior to measurement. 
 
3. DEFINITIONS  
Laboratory sample: sample as prepared for sending to the laboratory and intended for 
inspection or testing (i.e. the sample or subsample(s) received by the laboratory).  
Test sample: sample prepared from the laboratory sample and from which test portions will 
be taken.  
Test portion: the quantity of material drawn from the test sample and on which the test or 
observation is actually carried out (i.e. for this study the test portion is of 5 g).  
Final extract: solution containing the analytes; obtained after the last evaporation step and 
reconstitution of the extract.  
Labelled analogue: Stable isotope labelled analogues of MCPD and glycidyl esters. The 
labelled analogues are used to correct the losses of native compounds during analysis.  
Quantifier ion (Q1): ion monitored for quantifying the analytes.  
Qualifier ion (Q2): ion monitored in for confirmation of identity.  
Procedural blank: a sample made up of all reagents foreseen for the preparation of a test 
portion and processed in all respects as a test portion. This kind of blank, tests the purity of 
the reagents but also other possible sources of contamination, like the glassware and the 
analytical instrument. 
 
4. SAFETY 
Protective equipment such as laboratory coat, and safety glasses have to be used. All 
handlings of reagents and organic solvents should be performed in a fume hood with 
adequate air flow. 
3-MCPD is considered a potential carcinogen and just like its derivatives it is irritating to 
eyes, respiratory system and skin. Persons using these instructions should be familiar with 
normal laboratory practise. It is the responsibility of the user of these instructions to apply 
safety and health practices which are in agreement with the local requirements. 
 
5. STANDARDS 
The list of native substances and labelled analogues applied for the quantification of the 
target compounds included in the scope of this SOP are listed in Table 1. 
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5.1. Reference Substances 
Table 1. Name, CAS number, molecular formula and molecular weight of native and labelled 
analytes 
Name Acronym CAS # 
Molecular 
formula 
Molecular 
weight (g/mol) 
rac 1,2-bis-palmitoyl-3-
chloropropanediol 
3-MCPD ester 51930-97-3 C35H67ClO4 587.36 
rac 1,2-bis-palmitoyl-3-
chloropropanediol-d5 
3-MCPD-d5 
ester 
1185057-55-
9 
C35H62D5ClO4 592.39 
1,3-distearoyl-2-
chloropropanediol 
2-MCPD ester 26787-56-4 C39H75ClO4 643.46 
1,3-distearoyl-2-
chloropropanediol-d5 
2-MCPD-d5 
ester 
- C39H70D5ClO4 648.49 
glycidyl palmitate Gly-P 7501-44-2 C19H36O3 312.48 
glycidyl oleate-d5 Gly-O-d5  C21H33D5O3 343.56 
 
All 3-MCPD ester, 2-MCPD ester, Gly-P, 3-MCPD-d5 ester, 2-MCPD-d5 ester and Gly-O-d5 stock 
solutions are prepared in toluene and stored at 4 °C in the dark. The intermediate solutions of native 
substances and internal standards are prepared by diluting the stock solutions with toluene.  
 
 
 
 
 
 
 
 
6. CHEMICALS 
6.1. General  
Use only reagents of recognized analytical quality/standard, unless otherwise specified.  
Note: Commercially available solutions with equivalent properties to the reagents listed may 
be used.  
For storing of substances and commercially available solutions, supplier indications are 
followed. For opened commercial solutions or for in-house prepared solutions, the indications 
given in this procedure are intended to minimise the evaporation of the solvent and to protect 
the analytes from degradation. 
For the preparation of solutions of native or labelled compounds, a microbalance is used. All 
quantities are expressed as mass concentration (weight/volume). Intermediate standard 
solutions are prepared volumetrically. All solutions and substances are being used at 20 °C. 
 
1,2-Dipalmitoyl-3-chloropropanediol can be substituted by 1,2-dioleyl-3-chloropropanediol or other 
fatty acid diesters of 3-MCPD with similar chain length (C16-C18 should be preferred as they are 
the most abundant in the majority of fats/oils).  
Other diesters of 2-MCPDand glycidol can be used as well. 
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6.1.1. Tetrahydrofuran, anhydrous 
6.1.2. Methanol, analytical grade 
6.1.3. n-Hexane, analytical grade 
6.1.4. Ethyl acetate, analytical grade 
6.1.5. 2,2,4-trimethylpentane (Isooctane), analytical grade 
6.1.6. Diethyl ether, analytical grade 
6.1.7. Toluene, analytical grade 
6.1.8. tert-Butyl methyl ether (tBME), analytical grade 
6.1.9. Water, grade I according to ISO 3696:1995 (Millipore Milli-Q) 
6.1.10. Sulphuric acid (purity ≥ 95 %) 
6.1.11. Sodium hydrogen carbonate (purity ≥ 99 %) 
6.1.12. Sodium sulphate, anhydrous granular (purity ≥ 99 %) 
6.1.13. Ammonium sulphate (purity ≥ 99 %) 
6.1.14. Phenylboronic acid (PBA)(purity ≥ 97 %) 
6.1.15. Sodium bromide, anhydrous (purity ≥ 99.5 %) 
6.1.16. Sand, 50 – 70 mesh particle size 
6.1.17. Sodium polyacrylate, Poly(acrylic acid), partial sodium salt-graft-poly(ethylene oxide) 
granular, 90-850 μm particle size 
6.1.18. Reference material for quality control. A self-prepared test material may be applied 
for this purpose. 
6.1.19 3 mL SPE cartridges with 500 mg aminopropyl (NH2) e.g. Thermo Scientific 
TM 
HyperSep TM. 
6.1.20 Acetone, analytical grade 
6.1.21 petroleum ether, boiling point 40- 60 °C, analytical grade 
6.1.22 iso-Hexane, (2-methylpentane), analytical grade 
7. GASES 
7.1. Helium purified compressed gas (purity equivalent to 99.999 %)  
7.2. Nitrogen purified compressed gas 
 
8. APPARATUS 
8.1. 10 ml amber glass vials with PTFE layered screw caps 
8.2. Microbalance (if available), with a readability of 0.00001 g 
8.3. Analytical balance, with a readability of 0.0001 g 
8.4. Laboratory balance, with a readability of 0.01 g 
8.5. Porcelain mortar and pestle, capacity of the mortar shall be at least 200 ml.  
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8.6. Ultrasonic bath 
8.7. Vortex test tube shaker 
8.8. Pressurised liquid extraction (PLE) apparatus comprising the following: 
8.9. PLE cells, with 34 ml of volume 
8.10. Cellulose Filters, 30 mm diameter 
8.11. Sample carousel 
8.12. Degasser 
8.13. Extraction chamber 
8.14. Solvent collection bottles, 250 ml of volume 
8.15. Pressure control device, for the supply and release of the pressurizing gas in the 
extraction cell 
8.16. Temperature control device 
8.17. Instrument control and data processing system 
8.18. Evaporation apparatus: Rotary evaporator capable of evaporation under controlled 
temperature and vacuum. The evaporation apparatus shall be equipped with either round 
bottom flasks or glass tubes of appropriate volumes: approximately 250 ml for the 
evaporation of PLE extracts (approximately 100 ml). 
8.19. Glass Pasteur capillary pipettes, 230 mm length 
8.20. Centrifuge 
8.21. (Ceramic) knife or scalpel  
8.22. Gas-chromatography – mass spectrometry (GC-MS) apparatus including computerised 
instrument control and data evaluation 
8.23. Amber glass volumetric flasks, class A 
 
9. STANDARD PREPARATION 
The stock standard solutions are prepared gravimetrically. Intermediate solutions may be 
prepared volumetrically.  
The presented standard concentrations are indicative only! Correct values have to be 
calculated based on the exact concentrations after weighing. The standard concentrations 
have also to be corrected for purity of the reference substances. 
 
9.1. Single-substance stock solutions of native esters 
Prepare for native 3-MCPD esters, 2-MCPD esters, and glycidyl esters (listed in Table 1) a 
solution in toluene (6.1.7) with a concentration of ~ 1 mg/ml. The single standard stock 
solutions are prepared by weighing of 10 (±0.1) mg of each neat substance using the 
microbalance (8.2). The substance is transferred into a flask 10 mL, toluene is added and 
weighed on an analytical balance. To dissolve the substances, each solution shall be 
sonicated for a couple of minutes. These solutions will be used for the preparation of 
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calibration standards. Table 2 provides an overview on the standard concentrations of the 
ester-bound analytes and on the concentration, which is equivalent to the free form. 
The concentration of the stock solution is calculated using the mass fraction of the stock 
solution and the density of toluene (δ = 867 kg/m3). 
 
Table 2: List and concentrations of single substance stock solutions of esters 
Standard number Substance Concentration Free form equivalent 
9.1a 3-MCPD ester 1.0 mg/ml 188.2 µg/ml 
9.1b 2-MCPD ester 1.0 mg/ml 171.8 µg/ml 
9.1c Gly-P 1.0 mg/ml 237.1 µg/ml 
 
9.2. Single-substance stock solutions of stable isotope labelled MCPD and 
glycidyl esters 
Prepare, from stable isotope labelled 3-MCPD ester, 2-MCPD ester, and glycidyl ester (listed 
in Table 1), a solution in toluene (6.1.7) with a concentration of 1 mg/ml.  
 
 
 
 
 
The single standard stock solutions are prepared by weighing of 10 (±0.1) mg of each neat 
substance using the microbalance (8.2). The substance is transferred into a flask 10 mL 
toluene is added and weighed on an analytical balance. To dissolve the substances, each 
solution shall be sonicated for a couple of minutes. These solutions will be used for the 
preparation of the internal standard solution and for matrix matched calibration standards. 
Table 3 provides an overview on the standard concentrations of the ester-bound analytes 
and on the concentration which is equivalent to the free form. 
The concentration of the stock solution is calculated using the mass fraction of the stock 
solution and the density of toluene (δ = 867 kg/m3). 
Table 3: List and concentrations of single substance stock solutions of stable isotope 
labelled esters, including concentration expressed as free 3-MCPD, 2-MCPD, glycidol 
equivalents 
Standard number Substance Concentration Free form equivalent 
9.2a 3-MCPD-d5 ester 1.0 mg/ml 195.1 µg/ml 
9.2b 2-MCPD-d5 ester 1.0 mg/ml 178.2 µg/ml 
9.2c Gly-O-d5 1.0 mg/ml 230.3 µg/ml 
Calibration and analysis of samples are designed in a way that the exact concentration of 
the stock standard solution of stable isotope labelled esters is of minor importance. It is 
however of paramount importance to add both to the calibration solution and to the 
sample the same amount of stable isotope labelled standard. 
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9.3. Mixed intermediate labelled MCPD and glycidyl ester solution 
Prepare, with the individual stock solutions of labelled esters (9.2a, 9.2b, 9.2c) listed in 
Table 3 a mixed intermediate solution in toluene with a concentration of approximately 
25 μg/ml glycidyl esters and 50 μg/ml for MCPD esters by pipetting 1250 µl of standard stock 
solutions (9.2c) and 2500 µl each of the of standard stock solutions (9.2a, 9.2b) into a 50 ml 
volumetric flask (8.23) and fill up to mark with toluene. 
9.4. Mixed intermediate solution of native MCPD and glycidyl esters 
Prepare, from the single-substance stock solutions of native esters (9.1a, 9.1b, 9.1c), a 
mixed intermediate solution in toluene with a concentration of approximately 25 μg/ml 
glycidyl esters and 50 μg/ml for MCPD esters by pipetting 1250 µl of standard stock solutions 
(9.1c) and 2500 µl each of the of standard stock solutions (9.1a, 9.1b) into a 50 ml volumetric 
flask (8.23) and fill up to mark with toluene.  
9.5. Preparation of calibration standards 
Table 4 provides a scheme for the preparation of calibration standards for the analyte content range of 
about 100 μg kg
-1
 – 4 mg kg
-1
 for free forms of 2-MCPD and 3-MCPD and 50 μg kg
-1
 – 2 mg kg
-1
 for 
free form of glycidol in extracted fat. The amount of intermediate solution is pippeted into a 10 mL flask 
and the flask is filled up to the mark with toluene. The concentration values given in Table 4 are target 
values. The actual concentrations have to be calculated based on the actual concentration of the stock 
solutions. 
Table 4: Preparation scheme for calibration standards 
 
Volume of mixed intermediate 
solution of native MCPDEs and 
GEs (9.4) 
Nominal 
concentration of 
MCPDs (free form) 
Nominal 
concentration of 
Glycidol (free 
form) 
 mL μg/mL μg/mL 
Cal 1 0.1 0.1 0.05 
Cal 2 1 1 0.5 
Cal 3 2 2 1 
Cal 4 3 3 1.5 
Cal 5 4 4 2 
 
Table 5: MW values for the used MCPD and glycidyl esters and their corresponding free 
forms 
 MW ester MW free form 
3-MCPD ester 587.36 110.54 
3-MCPD-d5 ester 592.39 115.57 
2-MCPD ester 643.46 110.54 
2-MCPD-d5 ester 648.49 115.57 
Gly-P 312.48 74.08 
Gly-O-d5 343.56 79.11 
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9.6. Preparation of labelled MCPD and glycidyl ester solution 
2 mL of mixed intermediate labelled solution (9.3) is pippeted into a 10 mL flaked and the flask is filled 
up to the mark with toluene. 
100 μL of this solution will be used for the spiking into the fat extract and for calibration (for internal 
standardisation). Store this solution in the dark and at a temperature below 10 ºC. A solution stored in 
this way is stable for at least two months. If longer stability is proven, the solution can still be applied. 
 
9.7. Preparation of matrix matched calibration 
A matrix matched calibration is performed. Therefore 100 μl of each calibration standard and 
100 μl of mixed labelled ester solution (9.6) is added to 100 mg of blank oil. Additionally one 
'zero' level sample is prepared by adding 100 μl of toluene and 100 μl of mixed labelled ester 
solution (9.6) is added to 100 mg of blank oil. These samples undergo the same treatment as 
normal samples starting from point 11.4. 
 
 
 
 
 
10. SOLUTIONS 
10.1. Glycidyl conversion 
1. Acid aqueous solution of sodium bromide (3 mg/ml). Prepare a concentrated 
aqueous solution of sodium bromide by dissolving 1 g of sodium bromide (6.1.15) in 
10 ml of ultra-pure water (6.1.9). Transfer 180 μl of the concentrated solution into a 
10 ml volumetric flask (8.23). Add 5.5 ml of ultra-pure water (6.1.9) and afterwards 
0.3 ml of sulphuric acid (6.1.10). Shake vigorously. 
 
 
 
2. Sodium hydrogen carbonate solution (0.6 %, w/v). Weigh 0.6 g of sodium 
hydrogen carbonate (6.1.11)in a 100 ml volumetric flask and fill up to the mark with 
ultra-pure water (6.1.9). Use ultrasonic bath to ensure the complete dissolution of the 
reagent. 
10.2. Acid transesterification 
1. Transesterification reagent: Sulphuric acid/methanol solution (1.8 % v/v). Pipette 
50 ml of methanol (6.1.2) into an empty 100 ml volumetric flask, add afterwards 
1.8 ml of sulphuric acid (6.1.10) and fill then up to mark with methanol. (Note 1) 
 
 
2. Stop reagent: Sodium hydrogen carbonate solution (saturated). Weigh 4.8 g of 
sodium hydrogen carbonate (6.1.11) in a 50 ml volumetric flask and fill up to mark 
with ultra-pure water (6.1.9). Use an ultrasonic bath to ensure the dissolution of the 
reagent.  
The addition of 100 mg of blank oil to the calibration samples improves the robustness of the 
method, since the oil matrix helps retain the analytes during the evaporation step. 
 
It is advisable to freshly prepare the solution on daily basis 
It is advisable to freshly prepare the solution on daily basis 
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10.3. Ammonium sulphate solution 
Weigh 20 g of ammonium sulphate (6.1.13) in a 50 ml volumetric flask and fill up to the mark 
with ultra-pure water (6.1.9). Use ultrasonic bath to ensure dissolution of the reagent. 
10.4. Derivatisation reagent 
Dissolve 0.4 g of phenylboronic acid (PBA) (6.1.14) in 10 ml of diethyl ether (6.1.6). Shake 
vigorously.  
 
 
 
11. PROCEDURE  
11.1. Sample treatment 
As a general precaution, all of the sample material received by the laboratory shall be used 
for obtaining a representative and homogeneous laboratory sample without introducing 
contamination.  
11.2. Test sample preparation 
a) To obtain the test portion weigh, 5 g ± 0.1 g of the homogenised test sample into an 
aluminium weighing boat. Add 5 g of polyacrylic acid (6.1.17) and 15 g of sand (6.1.16).  Mix 
thoroughly until the sample is finely ground and visually homogeneous.  
The sand and the polyacrylic acid are weighed with a laboratory balance.  
b) Oils and margarines, consisting mostly of lipids, skip point 11.3 and follow directly from 
point 11.4. 
 
11.3. Sample extraction by PLE  
Transfer the test portion into the extraction cell of the PLE apparatus after having checked 
that all the seals and O-rings are in good status and having placed the filter.  
The extraction takes place under the following conditions:  
Table 6. Pressurized liquid extraction conditions 
Pressure 1500 psi 
Temperature 40 ºC 
Pre-heat time 5 minutes 
Heat time 5 min 
Static time 5 min 
Flush volume 60 % 
Purge time 180 seconds 
Static cycles 2 
Solvent: tert-Butyl methyl ether 100 % 
 
After the extraction, the extractant (< 60 ml) is decanted into the evaporation vessel with 
known tare weight and evaporated at 40 ºC until dryness. The weight of the evaporation 
vessel containing the extract is recorded after reaching constant weight. The difference 
between tare weight of the evaporation vessel and weight after evaporation of the extractant 
is attributed to the extracted oil/fat. 
Some batches of PBA do not dissolve in this solvent. Another batch has to be used in such case. 
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11.4. SPE, conversion and transesterification 
1. A portion of 100 mg of oil/fat (±5 mg) is transferred with a Pasteur pipette or a spatula 
into a 1.5 ml vial and 100 μl of mixed labelled ester solution (9.6) is added. Add 500 μl 
of n-hexane : ethylacetate (85+15, v/v) and shake vigorously on a vortex mixer for 15 
seconds. 
2. The SPE cartridge is conditioned with 2 mL n-hexane : ethylacetate (85+15, v/v). 
3. The sample is loaded onto the cartridge. 
4. The target compounds are eluted with 10 mL n-hexane : ethylacetate (85+15, v/v). The 
eluate is evaporated under a gentle stream of nitrogen at 40 °C. The residue is 
thereafter reconstituted in 2 mL tetrahydrofuran. 
 
 
 
5. Conversion: Add 30 μL of acid aqueous solution of sodium bromide (10.1.1) to the 
sample, shake vigorously (vortex) and incubate the mixture at 50 °C for 15 min. Stop 
the reaction by the addition of 3 ml of 0.6% aqueous solution of sodium hydrogen 
carbonate (10.1.2). In order to separate the oil/fat from the water phase, add 2 ml of n-
hexane (6.1.3) and shake vigorously. After separation of the two phases, transfer the 
upper layer to an empty test tube (8.1) and evaporate to dryness under a nitrogen 
stream (at 40 °C). Dissolve the residue (oil) in 1 ml of anhydrous tetrahydrofuran  
 
 
 
 
 
 
 
 
6. Acid transesterification: Add 1.8 ml of sulphuric acid/methanol solution to the sample 
and shake vigorously (vortex) for 10 s. Close the cap of the test tube (8.1) tightly and 
incubate the mixture at 40 °C for 16 h. After the incubation period, the ester cleavage is 
stopped by the addition of 0.5 ml sodium hydrogen carbonate saturated solution to the 
sample. Shake (vortex) for 10 s. Evaporate the organic solvent (methanol) of the 
mixture under a nitrogen stream at 40°C.  
 
 
 
7. Salting-out: Add 1.3 ml of ammonium sulphate solution. Add 1ml n-hexane and shake 
for 10 s with a vortex. Discard the upper phase that contains fatty acid methyl esters 
dissolved in n-hexane by using Pasteur pipettes. Repeat this step with another 1ml of 
n-hexane. 
IMPORTANT NOTE: SPE extraction could be omitted in case justified evidence exists that the 
sample is free from partial acylglycerols, in particular MAGs. 
Both time and temperature of the reaction must be carefully controlled to avoid either sub-
optimal conversion of glycidyl esters or ex-novo formation of 3-MBPD esters. 
The clear separation of the organic phase from the water phase can be difficult. Therefore, it 
might be necessary to centrifuge the sample. 
The evaporation of the organic phase under nitrogen stream must be carefully monitored and 
stopped immediately after the evaporation of the solvent. 
The removal of organic solvent enhances the sensitivity of the method. The evaporation can be 
stopped when, upon visual check, the volume in the tube is about 1 mL 
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8. Extraction: Extract the free form of 2- and 3-MCPD as well as 3-MBPD from the 
aqueous phase with 3 x 0.6 ml of ethyl acetate, shake each time for 10 s (vortex) and 
transfer the upper phases to an empty glass test tube containing a small amount of 
anhydrous sodium sulphate.  
9. Derivatisation: Add 150μl of the derivatisation reagent to the organic solvent (1.8 ml of 
ethyl acetate), shake for 15s and incubate in an ultrasonic bath for 5 minutes. To 
complete the derivatisation reaction, evaporate the extracts to dryness at 40 °C under a 
low stream of nitrogen.  
10. Dissolve the residue in 300 μl of isooctane by shaking the mixture for 10 s (vortex), 
centrifuge the final solution at 3500 rpm and transfer the supernatant to an empty GC 
vial (a glass insert of about 150 μl of volume is typically used). 
 
 
 
 
 
 
 
 
12. INSTRUMENTAL CONDITIONS 
12.1. GC conditions 
(a) Injection volume: 1.0 μL 
(b) Injection mode: pulsed splitless 
Pulse pressure: 200 kPa 
Pulse time: 0.30 min 
Purge flow: 30.0 ml/min 
Purge time: 2.0 min 
(c) Injection temperature: 250 °C 
(d) Carrier gas: helium 
(e) Flow rate: 1.2 ml/min 
(f ) Temperature program: 60 °C (1 min), from 60 °C to 150°C at 6 °C/min, 2 min at 150 oC, 
from 150 °C to 300 °C at 10 °C/min. 
 
12.2. MS conditions  
(a)  Transfer line temperature: 300 °C 
The evaporation of the extracts under nitrogen stream can be carried out at maximum of 40 °C 
to facilitate the evaporation of ethyl acetate, but it must be stopped as soon as the solvent is 
evaporated in order to avoid loss of the highly volatile phenylboronic derivatives. 
If the evaporation of extracts is carried out at elevated temperatures the test tube must be 
allowed to cool down to room temperature before dissolving the residue. 
During the second extraction, it is important to remove the upper organic phase completely 
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(b)  Ion source temperature: 250 °C 
(c)  Quadrupole temperature: 150 °C 
(d)  Ionization mode: EI, SIM mode 
(e)  Parameters for SIM mode: 
(i) phenylboronic derivative of 3-MCPD (m/z): 147 (Q1); 196 (Q2); 
(ii) phenylboronic derivative of 3-MCPD-d5 (m/z): 150 (Q1); 201 (Q2) 
(iii) phenylboronic derivative of 2-MCPD (m/z): 196 (Q1); 198 (Q2); 
(iv) phenylboronic derivative of 2-MCPD-d5 (m/z): 201 (Q1); 203 (Q2) 
(v) phenylboronic derivative of 3-MBPD (m/z): 242 (Q1); 147 (Q2); 
(vi) phenylboronic derivative of 3-MBPD-d5 (m/z): 245 (Q1); 150 (Q2). 
Acquisition time window: 5-20 min. 
 
Table 8. Retention times and m/z-ratios of native and stable isotope labelled MCPDs and 
MBPD. 
Compounds 
Retention time,  
(min) 
Q1 , (m/z) Q2 , (m/z) 
3-MCPD-d5 17.25 150 201 
3-MCPD 17.33 147 196 
2-MCPD-d5 18.02 201 203 
2-MCPD 18.13 196 198 
3-MBPD-d5 19.49 245 150 
3-MBPD 19.57 242 147 
 
 
 
 
 
 
 
12.3. Sample Analysis 
Each sequence encompasses a procedural blank to assess interferences/contamination 
deriving from the applied reagents and apparatus. A reference material (quality control 
sample) shall be also included in the batch, for checking the method performances along 
time. Calibration standards are also injected at the end of the sequence, or after at least 10 
sample injections. 
 
 
Ions (m/z 196 and 201 for 3-MCPD and 3-MCPD-d5, respectively and m/z 150 and 147 for 3-
MBPD and 3-MBPD-d5, respectively) can also be used for quantification purposes. 
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13. DATA ANALYSIS & REPORTING 
13.1. Calibration curve  
The calibration curve is obtained by plotting the signal ratios of the PBA derivatives of the 
native analytes and the PBA derivatives of the corresponding labelled standards on the 
abscissa, against the amounts of native analytes (expressed in ng of free 3-MCPD, 2-
MCPD, glycidol equivalent) added into the test tube prior to derivatisation.  
Ions at m/z 147 (3-MCPD), 150 (3-MCPD-d5), 196 (2-MCPD), 201 (2-MCPD-d5), 240 (3-
MBPD) and 245 (3-MBPD-d5) are used for quantification. The calibration function is defined 
for each analyte by linear regression, and can be described by Equation 2. 
bCa
A
A
native
labelled
native     Equation 2 
Where: 
nativeA  is the area of the quantifier ion of the native analyte peaks  
labelledA  is the area of the corresponding stable isotope labelled analogue peaks  
a   is the slope of the calibration function 
nativeC  is the amount of native analytes added into the test tube prior to derivatisation 
(in ng) 
b  is the intercept of the calibration function 
 
The injections of calibration standards shall be performed in random order. 
 
13.2. Calculations 
The concentration of the free form of analyte in the sample is reported in μg/kg according to 
Eq. 3. 
fatsample
labelled
native
native
W
a
b
A
A
X
/







    Equation 3 
Xnative  is the concentration of native analytes (in µg/kg) in the analysed fat /test sample. 
nativeA   is the area of the native analyte peak of the test sample  
labelledA   is the area of the corresponding stable isotope labelled analyte peak  
Wsample/fat: a) weight of the extracted fat used for further analysis, or b) weight of test portion, 
if mixed labelled ester process solution (9.6) was added to the test portion prior to extraction 
(both values in g) 
 
The conversion of the analyte content expressed on fat basis into analyte content expressed 
on product basis (µg/kg) is described by Equation 4: 
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𝐶𝑃 = 𝑋𝑛𝑎𝑡𝑖𝑣𝑒 ∗
𝐹𝑒𝑥𝑡𝑟𝑎𝑐𝑡𝑒𝑑
𝑊𝑠𝑎𝑚𝑝𝑙𝑒
            Equation 4 
 
Cp:  Concentration of the native compound in the sample (in µg/kg) 
Fextracted:  Amount of fat extracted from the test portion (in g) 
Wsample:  Weight of the test portion (in g) 
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ANNEX 1: WORK FLOW FOR THE ANALYSIS OF ESTER-BOUND 3-MCDP, 2-MCDP AND GLYCIDOL 
 
 
Evaporate and reconstitute
 in 2 mL tetrahydrofuran (THF)
Glycidyl conversion
+30 µl acidic aqueous NaBr
+3 ml stop reagent
(0.6 % v/v NaHCO )
3
Extraction of esters into 
2 mL n-hexane
evaporate organic phase
dissolve in 1 mL THF
Discard aqueous phase
Acidic transesterification
+ 1.8 mL H SO /methanol 
at 40 °C for 16 h
stop reaction with
0.5 mL saturated  
2 4
NaHCO3
Evaporation of MeOH
salting of aqueous phase
+ 1.3 mL ammonium-
 sulphate solution
Defatting
extract 2 x with 
1 ml n-hexane
Discard organic phase
Extraction of free forms 
from aqueous phase
3 x 0.6 ml ethyl acetate
Discard aqueous phase
Derivatisation
 in organic phase
+ 150 µL PBA in diethyl ether
Evaporation, reconstitution
 in 0.3 ml isooctane,
centrifugation
GC-MS analysis
of supernatant
5 g finely ground and
 homogenized sample
Oil or fat
No
Yes
Pressurised liquid extraction
 after addition of 
5 g polyacrylate + 15 g sand
Evaporation  of solvent at 40 °C
100 ± 5 mg fat
Addition of
internal standard
Dissolve in 500 µL
n-hexan/ethylacetate 
(85+15 v/v)
SPE
condition with 2 mL 
n-hexane/ethylacetate
(85+15 v/v)
Load sample
Elute and collect with 10 mL
 n-hexane/ethylacetate
 (85+15 v/v)
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